NewAmsterdam Pharma Company NV will host an R&D Day event on June 11, 2025, in New York City. The late-stage clinical biopharmaceutical company will present its developments in oral, non-statin medicines for patients at risk of cardiovascular disease with elevated LDL-C. The event will feature members of the management team, and a live webcast will be available for virtual attendees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9463642-en) on June 05, 2025, and is solely responsible for the information contained therein.